Understanding quality of life for patients with implantable cardioverter defibrillators
Patient-Reported Quality of Life in Patients With an Implantable-Cardioverter Defibrillator - A Cross-Sectional Observational Study
This study is trying to understand how having an implantable cardioverter-defibrillator affects the daily lives and well-being of patients.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 800 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Universitaire Ziekenhuizen KU Leuven Academic / other |
| Locations | 1 site (Leuven) |
| Trial ID | NCT06654232 on ClinicalTrials.gov |
What this trial studies
This observational study aims to gather insights into the quality of life (QoL) of patients who have received an implantable cardioverter-defibrillator (ICD). It focuses on various aspects of QoL, including physical and emotional health, acceptance of the ICD, and concerns related to physical and sexual activity. By utilizing quality of life questionnaires, the study will capture patient-reported outcomes to better understand the challenges faced by these individuals. The findings could inform future patient care and support strategies.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older who have any type of ICD and are being followed at UZ Leuven.
Not a fit: Patients who are hospitalized, have a mental disability, or are already participating in another interventional study may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the understanding of the challenges faced by ICD patients, leading to improved support and interventions that enhance their quality of life.
How similar studies have performed: While there have been studies on quality of life in ICD patients, this specific observational approach focusing on patient-reported outcomes is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥ 18 years of age * Patients with any type of ICD followed in UZ Leuven * Willing and able to provide signed written informed consent Exclusion Criteria: * Patients who are hospitalized * Patients with a mental disability * Patients already included in another interventional study
Where this trial is running
Leuven
- UZ Leuven — Leuven, Belgium (Recruiting)
Study contacts
- Study coordinator: Bert Vandenberk, MD PhD
- Email: bert.vandenberk@uzleuven.be
- Phone: +3216338686
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.